Paulo Hernandes Marques Palmeira

Co-founder and CEO of InsilicAll, the first Drug Discovery platform in Latin America, which optimizes the development of new drugs by reducing costs and time, as well as providing solutions for toxicological safety assessments in the registration of new products. InsilicAll received a pre-seed investment of R$150,000 from BiotechTown, an innovation hub focused on Biotechnology and Life Sciences, and recently raised a seed investment of R$500,000 from the American multinational Alvarez Marsal (AM) through its venture capital fund, Next.I am actively involved in the management of the company, responsible for the administration of teams and projects. Since the founding of InsilicAll, I have also led the commercial sector, engaging directly with clients, managing sales processes, post-sales, and fostering long-term relationships with our partners.Our startup has been recognized by ABIQUIFI and Apex-Brasil in the Brazilian Pharma Health (BPH) program, which mapped out prominent startups in the healthcare sector, identifying us as "hidden champions," with a focus on attracting investments and internationalizing innovative solutions.My experience includes bioinformatics, fundraising, and the implementation of artificial intelligence and machine learning models focused on the pharmaceutical and biotech sectors.My entrepreneurial journey began as Director and co-founder of the junior company ByTechnology (UFG), where I participated in the business incubation program at the CEI/UFG entrepreneurship center. I was a consecutive finalist in two editions of the Entrepreneurship Olympics for University Students from Goiás (2016-2017) and raised funds for technological innovation projects.I served as Director of Bioplace (2016-2017), a startup awarded 2nd place at the Biostartup Lab (2017) and finalist at Inovativa Brasil (2017). I was selected as a Public-Private Matchmaking Agent in Biotechnology for Mercosur by Biotecsur Network.My expertise includes the curation of public and private data, creation of predictive models, and technical support in artificial intelligence modeling. I participated in the BiotechTown Business Development Program (2019), expanding my network of contacts and strategic partnerships in the Biotechnology and Life Sciences sectors.